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Objective
To assess the diagnostic accuracy of CMR parameters in
predicting future major cardiovascular adverse events
(MACE) in patients with suspected arrhythmogenic right
ventricular cardiomyopathy (ARVC).
Background
ARVC is one of the commonest causes of sudden cardiac
death amongst people younger than 30 years. Establishing
the diagnosis still remains a difficult task, since there is as
yet no single non-invasive gold standard test to confirm it.
It is therefore essential to identify within a population
with suspected ARVC, a subset who will indeed be at a
higher risk of developing the disease, and thus at a higher
risk of MACE. Imaging criteria that are most commonly
studied include right ventricular volumes, ejection frac-
tion and regional wall motion abnormalities. We sought
to determine which imaging parameters were better pre-
dictors of worse clinical outcomes.
Methods
We included 379 consecutive patients referred for CMR
examination between 2002 and 2005, with suspected
ARVC based on at least one minor criterion as defined by
the Task Force Criteria. Patients were classified according
to their initial scans as either "normal" or "abnormal".
Scans were abnormal if RV end-diastolic volume (RVEDV)
was increased, or RV ejection fraction (RVEF) was
decreased, or late gadolinium enhancement of the LV
(LVLGE) or RV (RVLGE) was present. Cut-off values for
normal versus abnormal RVEDV and RVEF were based on
previously published reference ranges indexed for BSA
and adjusted for age, from our institution. Follow-up data
was obtained in 2009 for all patients, and reviewed by two
independent researchers. MACE were all cause-mortality,
occurrence of life-threatening arrhythmias, appropriate
ICD discharge, and unplanned hospital admission for car-
diovascular events. Cox proportional hazards analysis was
performed to assess the excess risk associated with each
CMR variable.
Results
The average age was 43.6 ± 15.8 years; 199 were males
(52.5%). 61 patients (16%) had increased RVEDV at base-
line examination, 90 had decreased RVEF (24%), 19 had
LVLGE, and 6 had RVLGE. The positive predictive value
for MACE was 21% for RVEDV, 22% for RVEF, 26% for
LVLGE and 33% for RVLGE. The hazards ratio was statis-
tically significant for RVEF [2.05 (95% CI 1.14-3.67; p
value 0.016)] only.
Conclusion
Each of these imaging parameters tends to predict worse
clinical outcomes in patients referred for suspected ARVC,
regardless of whether the actual diagnosis of ARVC is
established or not. However, amongst these, decreased
RVEF is significantly associated with an increased risk of
major adverse cardiovascular events.
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